Effect of sarilumab on unacceptable pain and inflammation control in Japanese patients with moderately-to-severely active rheumatoid arthritis: Post hoc analysis of a Phase III study (KAKEHASI).
Modern rheumatology（2023）
摘要
Sarilumab treatment reduced UP and inflammation in Japanese patients with rheumatoid arthritis.
更多查看译文
关键词
rheumatoid arthritis,active rheumatoid arthritis,sarilumab,moderately-to-severely
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要